Geoffrey Higgins
Associate Professor
- Honorary Consultant Clinical Oncologist, Oxford University Hospitals NHS Trust
- Medical Research Fellow, Corpus Christi College
Research Summary
My research focuses on finding new ways of making tumours more sensitive to radiotherapy treatment.
Biography
Geoff Higgins is an Associate Professor in the Oxford Institute for Radiation Oncology, having held a Cancer Research UK Clinician Scientist award since 2011.
He is an Honorary Consultant Clinical Oncologist in Oxford University Hospitals NHS Trust and is a Medical Research Fellow at Corpus Christi College.
He previously undertook specialist medical training at the Edinburgh Cancer Centre before moving to Oxford as a Cancer Research UK Clinical Research Fellow in 2007.
GROUP MEMBERS
Recent publications
-
Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non-Small Cell Lung Cancer.
Journal article
Skwarski M. et al, (2021), Clin Cancer Res
-
Targeting TOPK sensitises tumour cells to radiation-induced damage by enhancing replication stress.
Journal article
Herbert KJ. et al, (2020), Cell Death Differ
-
External Beam Radiation Therapy and Enadenotucirev: Inhibition of the DDR and Mechanisms of Radiation-Mediated Virus Increase.
Journal article
Pokrovska TD. et al, (2020), Cancers (Basel), 12
-
Corrigendum: Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?
Journal article
Wilson JD. et al, (2020), Front Oncol, 10
-
Targeting tumor hypoxia
Chapter
Skwarski M. et al, (2020), Cancer Drug Discovery and Development, 265 - 299